FAS and prostate carcinoma: Extensive evidence shows that the overexpression of certain lipogenic enzymes 6, especially fatty acid synthase (FAS) 7,8, is a common feature in tumor cells, including in gastric cancer, lung cancer, breast cancer 8,9,10 and prostate cancer 11,12,13.